CTI acquires Eurotrials to create ‘one of the 20 largest CROs in the world’
CTI Clinical Trial and Consulting Services (CTI) and Eurotrials have consolidated to create a full-service contract research organization (CRO) with a global footprint.
Archives for December 11, 2017
Plasticell banks on research organisation for cord-blood recruitment
Plasticell has teamed with Anthony Nolan to access the latter’s cord-blood bank and boost patient recruitment for its allogeneic haematopoietic stem cell transplantation (HSCT) therapy trials.
Charles River expands CRISPR/Cas9 service offering
It is an “exciting time in drug discovery,” says Charles River CSO as the company expands its CRISPR/Cas9 service offering with a license from ERS Genomics.
Otsuka pharma teams up with ‘site-less’ clinical trials firm to accelerate research
Science 37 and Otsuka Pharmaceutical have announced a strategic collaboration through which the global healthcare company aims to explore patient-centric clinical trials – “with fewer physical restrictions and greater efficiencies,” says CEO.
Emergent eyes capacity boost for anti-nerve gas auto-injector
Emergent BioSolutions says it is looking to expand auto-injector manufacturing capacity due to growing demand for its nerve agent antidote product Trobigard.
MHRA finds evidence of data integrity issues at Acme Lab's plant
UK regulators have issued Bangladesh-based drug maker The Acme Laboratories Limited a statement of GMP non-compliance after finding a plant inspection.
Granules hit by FDA 483 with one observation at ex-Valeant VA plant
The US FDA made one observation at the finished dose formulation in Chantilly, Virginia bought by Indian drugmaker Granules from Valeant Pharmaceuticals in 2014.